Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer’s Disease

[1]  C. Becker,et al.  Prion protein—Semisynthetic prion protein (PrP) variants with posttranslational modifications , 2019, Journal of peptide science : an official publication of the European Peptide Society.

[2]  M. Luo,et al.  Prion dimer is heterogenous and is modulated by multiple negative and positive motifs. , 2019, Biochemical and biophysical research communications.

[3]  D. Raha,et al.  Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors , 2019, Science Advances.

[4]  Jie Chen,et al.  Glycosylation Significantly Inhibits the Aggregation of Human Prion Protein and Decreases Its Cytotoxicity , 2018, Scientific Reports.

[5]  Joanne Rich,et al.  Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups , 2018, bioRxiv.

[6]  Y. Fang,et al.  Genetic association of the cytochrome c oxidase-related genes with Alzheimer’s disease in Han Chinese , 2018, Neuropsychopharmacology.

[7]  Nathan D. Price,et al.  Summary of the 11th International Conference on Human Herpesviruses‐6A, ‐6B, and ‐7 , 2018, Neuron.

[8]  J. H. Viles,et al.  Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a Drosophila model of Alzheimer's disease , 2018, The Journal of Biological Chemistry.

[9]  D. Stephan,et al.  An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk , 2018, Neurobiology of Aging.

[10]  S. Prusiner,et al.  β-Amyloid Prions and the Pathobiology of Alzheimer's Disease. , 2018, Cold Spring Harbor perspectives in medicine.

[11]  Chaoyang Li.  Prion protein is required for tumor necrosis factor alpha (TNFα)‐triggered nuclear factor kappa B (NF‐κB) signaling and cytokine production. , 2018 .

[12]  J. Hardy,et al.  Alzheimer's disease , 2018, European journal of neurology.

[13]  J. Leszek,et al.  The Infectious Etiology of Alzheimer’s Disease , 2017, Current neuropharmacology.

[14]  Jun Wang,et al.  Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production , 2017, The Journal of Biological Chemistry.

[15]  R. Itzhaki.  Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  L. Lannfelt,et al.  Decreased HHV-6 IgG in Alzheimer’s Disease , 2017, Front. Neurol..

[17]  O. Uthman.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. , 2016, Lancet.

[18]  Ying Zhu,et al.  Glycan-deficient PrP stimulates VEGFR2 signaling via glycosaminoglycan. , 2016, Cellular signalling.

[19]  C. Betzel,et al.  Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta‐mediated neurotoxicity , 2016, Journal of neurochemistry.

[20]  J. Schott.  Infection, inflammation and Alzheimer's disease , 2015, European journal of neurology.

[21]  A. Hill,et al.  The prion protein constitutively controls neuronal store-operated Ca2+ entry through Fyn kinase , 2015, Front. Cell. Neurosci..

[22]  J. Gilthorpe,et al.  Reactivated herpes simplex infection increases the risk of Alzheimer's disease , 2015, Alzheimer's & Dementia.

[23]  A. Vortmeyer,et al.  Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models* , 2015, The Journal of Biological Chemistry.

[24]  P. Wolf,et al.  Gender and incidence of dementia in the Framingham Heart Study from mid-adult life , 2015, Alzheimer's & Dementia.

[25]  C. Dobson,et al.  Single-Molecule Imaging Reveals that Small Amyloid-β1–42 Oligomers Interact with the Cellular Prion Protein (PrPC) , 2014, ChemBioChem.

[26]  D. Dunstan,et al.  A brief overview of amyloids and Alzheimer's disease , 2014, Protein science : a publication of the Protein Society.

[27]  S. Strittmatter,et al.  Therapeutic Molecules and Endogenous Ligands Regulate the Interaction between Brain Cellular Prion Protein (PrPC) and Metabotropic Glutamate Receptor 5 (mGluR5)* , 2014, The Journal of Biological Chemistry.

[28]  S. Prusiner,et al.  Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients , 2014, Proceedings of the National Academy of Sciences.

[29]  S. Prusiner,et al.  Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice , 2014, Proceedings of the National Academy of Sciences.

[30]  L. Spinney.  Alzheimer's disease: The forgetting gene , 2014, Nature.

[31]  Lihua Zhang,et al.  Prion protein and cancers. , 2014, Acta biochimica et biophysica Sinica.

[32]  Lifeng Yang,et al.  Prion Protein Participates in the Protection of Mice from Lipopolysaccharide Infection by Regulating the Inflammatory Process , 2014, Journal of Molecular Neuroscience.

[33]  C. Porro,et al.  Biological role of Toll-like receptor-4 in the brain , 2014, Journal of Neuroimmunology.

[34]  H. Schlüter,et al.  High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease. , 2014, Brain : a journal of neurology.

[35]  E. Masliah,et al.  Herpes virus in Alzheimer's disease: relation to progression of the disease , 2014, Neurobiology of Aging.

[36]  Ottavio Arancio,et al.  Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors , 2014, PloS one.

[37]  P. Vemuri,et al.  Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences , 2014, Clinical epidemiology.

[38]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[39]  A. Vortmeyer,et al.  Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein , 2013, Neuron.

[40]  Peter R Schofield,et al.  The Genetics of Dementia , 2013 .

[41]  Bin Zhang,et al.  Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons , 2013, Cell.

[42]  J. Weuve,et al.  Alzheimer disease in the United States (2010–2050) estimated using the 2010 census , 2013, Neurology.

[43]  N. Hooper,et al.  Prion Protein-mediated Toxicity of Amyloid-β Oligomers Requires Lipid Rafts and the Transmembrane LRP1* , 2013, The Journal of Biological Chemistry.

[44]  Cornelia M. Wilson,et al.  Tau protein kinases: Involvement in Alzheimer's disease , 2013, Ageing Research Reviews.

[45]  M. Gobbi,et al.  An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo* , 2013, The Journal of Biological Chemistry.

[46]  Deming Zhao,et al.  Cellular Prion Protein Participates in the Regulation of Inflammatory Response and Apoptosis in BV2 Microglia During Infection with Mycobacterium bovis , 2013, Journal of Molecular Neuroscience.

[47]  J. H. Viles,et al.  The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  D. Bennett,et al.  The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease , 2012, The Journal of Neuroscience.

[49]  Thomas C. Südhof,et al.  Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities , 2012, The Journal of Neuroscience.

[50]  R. Tanzi.  The genetics of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[51]  A. Vortmeyer,et al.  Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.

[52]  B. Riveau,et al.  Requirement of cellular prion protein for intestinal barrier function and mislocalization in patients with inflammatory bowel disease. , 2012, Gastroenterology.

[53]  Anne M. Remes,et al.  Molecular Genetic Analysis of the APP, PSEN1, and PSEN2 Genes in Finnish Patients With Early-onset Alzheimer Disease and Frontotemporal Lobar Degeneration , 2012, Alzheimer disease and associated disorders.

[54]  Stephen J. DeArmond,et al.  Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions , 2012, Proceedings of the National Academy of Sciences.

[55]  R. Tanzi,et al.  Role of common and rare APP DNA sequence variants in Alzheimer disease , 2012, Neurology.

[56]  Wei Yang,et al.  Air Pollution, Oxidative Stress, and Alzheimer's Disease , 2012, Journal of environmental and public health.

[57]  Guojun Bu,et al.  Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[58]  A. Nicot,et al.  Exacerbation of experimental autoimmune encephalomyelitis in prion protein (PrPc)-null mice: evidence for a critical role of the central nervous system , 2012, Journal of Neuroinflammation.

[59]  S. Lipton,et al.  Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-d-aspartate receptors , 2012, Proceedings of the National Academy of Sciences.

[60]  Stefan F. T. Weiss,et al.  Global Alzheimer Research Summit , 2012, Prion.

[61]  Alun Williams,et al.  Amyloid-β-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins , 2011, The Journal of Biological Chemistry.

[62]  Richard Mayeux,et al.  Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors , 2011, Genetics in Medicine.

[63]  L. Cendron,et al.  Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity. , 2011, The international journal of biochemistry & cell biology.

[64]  M. Hoch,et al.  Extracellular phosphorylation of the amyloid β‐peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease , 2011, The EMBO journal.

[65]  M. Rowan,et al.  Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein , 2011, The Journal of Neuroscience.

[66]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[67]  Chengjie Xiong,et al.  Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease , 2011, Alzheimer's Research & Therapy.

[68]  S. Faraone,et al.  Review Article: Genetics of Alzheimer Disease , 2010, Journal of geriatric psychiatry and neurology.

[69]  S. Strittmatter,et al.  Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse , 2010, BMC Neuroscience.

[70]  Jason J. Corneveaux,et al.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. , 2010, Human molecular genetics.

[71]  V. Pankratz,et al.  Replication of CLU, CR1, and PICALM associations with alzheimer disease. , 2010, Archives of neurology.

[72]  J. Falsig,et al.  Prion protein and Aβ-related synaptic toxicity impairment , 2010, EMBO molecular medicine.

[73]  W. Surewicz,et al.  Interaction between Human Prion Protein and Amyloid-β (Aβ) Oligomers , 2010, The Journal of Biological Chemistry.

[74]  S. Strittmatter,et al.  Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein , 2010, The Journal of Neuroscience.

[75]  K. Jellinger,et al.  Prevalence of dementia disorders in the oldest-old: an autopsy study , 2010, Acta Neuropathologica.

[76]  T. Zako,et al.  Amyloid oligomers: formation and toxicity of Aβ oligomers , 2010, The FEBS journal.

[77]  L. Stitz,et al.  Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling , 2010, Brain : a journal of neurology.

[78]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[79]  M. Gobbi,et al.  Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein , 2010, Proceedings of the National Academy of Sciences.

[80]  C. Glabe,et al.  Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction , 2009, Neurobiology of Disease.

[81]  W. M. van der Flier,et al.  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. , 2009, JAMA.

[82]  P. Paoli,et al.  PrPc activation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin‐1 in the signal transduction pathway , 2009, Journal of neurochemistry.

[83]  S. Sensi,et al.  Alzheimer's disease, metal ions and metal homeostatic therapy. , 2009, Trends in pharmacological sciences.

[84]  G. Zamponi.  Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. , 2009 .

[85]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[86]  F. Jirik,et al.  Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis. , 2008, The American journal of pathology.

[87]  Jia Longfei,et al.  PRNP mutations in a series of apparently sporadic neurodegenerative dementias in China , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[88]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[89]  N. Ben-Tal,et al.  Stress‐protective signalling of prion protein is corrupted by scrapie prions , 2008, The EMBO journal.

[90]  T. Bird.  Genetic aspects of Alzheimer disease , 2008, Genetics in Medicine.

[91]  M. Wozniak,et al.  Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation , 2007, Neuroscience Letters.

[92]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[93]  W. Banks,et al.  Aluminum complexing enhances amyloid β protein penetration of blood–brain barrier , 2006, Brain Research.

[94]  D. Walsh,et al.  Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.

[95]  G. Schellenberg,et al.  Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease. , 2006, Archives of neurology.

[96]  Hilkka Soininen,et al.  Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study , 2006, The Lancet Neurology.

[97]  Henrik Zetterberg,et al.  Alzheimer's disease , 2006, The Lancet.

[98]  K. Beyer.  α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers , 2006, Acta Neuropathologica.

[99]  T. Bliss,et al.  Plasticity in the human central nervous system. , 2006, Brain : a journal of neurology.

[100]  M. Tsolaki,et al.  Relationship between Helicobacter pylori infection and Alzheimer disease , 2006, Neurology.

[101]  R. Martins,et al.  Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes , 2006, Neurobiology of Aging.

[102]  D. Schuppan,et al.  Helicobacter pylori upregulates prion protein expression in gastric mucosa: a possible link to prion disease. , 2005, World journal of gastroenterology.

[103]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[104]  L. Mucke,et al.  Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[105]  T. Wisniewski,et al.  An Aggregation-Specific Enzyme-Linked Immunosorbent Assay: Detection of Conformational Differences between Recombinant PrP Protein Dimers and PrPSc Aggregates , 2005, Journal of Virology.

[106]  P. Lantos,et al.  Overlap between neurodegenerative disorders , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

[107]  E. M. Jones,et al.  Fibril Conformation as the Basis of Species- and Strain-Dependent Seeding Specificity of Mammalian Prion Amyloids , 2005, Cell.

[108]  R. Linden,et al.  The cellular prion protein modulates phagocytosis and inflammatory response , 2005, Journal of leukocyte biology.

[109]  G. Wilcock,et al.  Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients , 2005, Journal of medical virology.

[110]  M. Mattson,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[111]  I. Grundke‐Iqbal,et al.  Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.

[112]  P. Deyn,et al.  Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients , 2004, Journal of Neurology.

[113]  Susan Lindquist,et al.  Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein , 2003, Science.

[114]  F. Denaro,et al.  Coexistence of Alzheimer disease neuropathology with herpes simplex encephalitis. , 2003, Cellular and Molecular Biology.

[115]  N. Hooper,et al.  ADAMs family members as amyloid precursor protein α‐secretases , 2003 .

[116]  J. Regula,et al.  Reconstitution of γ-secretase activity , 2003, Nature Cell Biology.

[117]  Reinhard Jahn,et al.  A Broken α-Helix in Folded α-Synuclein* , 2003, The Journal of Biological Chemistry.

[118]  M. V. van Breemen,et al.  Amyloid β plaque-associated proteins C1q and SAP enhance the Aβ1–42 peptide-induced cytokine secretion by adult human microglia in vitro , 2003, Acta Neuropathologica.

[119]  M. Sy,et al.  Cell-surface prion protein interacts with glycosaminoglycans. , 2002, The Biochemical journal.

[120]  H. Budka,et al.  Mutations of the Prion Protein Gene , 2002, Journal of Neurology.

[121]  J. Sodroski,et al.  Stimulation of Enveloped Virus Infection by β-Amyloid Fibrils* , 2002, The Journal of Biological Chemistry.

[122]  Y. Kitamura,et al.  NACP/α-Synuclein, NAC, and β-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases , 2002, Acta Neuropathologica.

[123]  J. Trojanowski,et al.  Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[124]  G. Wilcock,et al.  Herpesviruses in brain and Alzheimer's disease , 2002, The Journal of pathology.

[125]  G. Riviere,et al.  Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. , 2002, Oral microbiology and immunology.

[126]  K. Arima,et al.  Tubulin Seeds α-Synuclein Fibril Formation* , 2002, The Journal of Biological Chemistry.

[127]  Seung-Jae Lee,et al.  Membrane-bound α-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form* , 2002, The Journal of Biological Chemistry.

[128]  M. J. Wade,et al.  Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. , 2001, Archives of neurology.

[129]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[130]  B. Steinhoff,et al.  Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[131]  H. Lipp,et al.  Learning deficits in mice with persistent Borna disease virus infection of the CNS associated with elevated chemokine expression , 2001, Behavioural Brain Research.

[132]  Y. Ono,et al.  Phosphorylation of Tau Is Regulated by PKN* , 2001, The Journal of Biological Chemistry.

[133]  T. Suzutani,et al.  Direct and mononuclear cell mediated effects on interleukin 6 production by glioma cells in infection with herpes simplex virus type 1 , 2001, Journal of medical virology.

[134]  L A Beckett,et al.  Is the risk of developing Alzheimer's disease greater for women than for men? , 2001, American journal of epidemiology.

[135]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[136]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[137]  V. Haroutunian,et al.  Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. , 2000, Archives of neurology.

[138]  A. Roher,et al.  Evidence for Seeding of β-Amyloid by Intracerebral Infusion of Alzheimer Brain Extracts in β-Amyloid Precursor Protein-Transgenic Mice , 2000, The Journal of Neuroscience.

[139]  B. Hyman,et al.  Membrane Association and Protein Conformation of α-Synuclein in Intact Neurons , 2000, The Journal of Biological Chemistry.

[140]  B. Dubois,et al.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. , 1999, American journal of human genetics.

[141]  T. Wight,et al.  The Sulfate Moieties of Glycosaminoglycans Are Critical for the Enhancement of β‐Amyloid Protein Fibril Formation , 1999, Journal of neurochemistry.

[142]  S. Bansil,et al.  Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis , 1999, Acta neurologica Scandinavica.

[143]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[144]  E. Tschachler,et al.  Human keratinocytes express cellular prion-related protein in vitro and during inflammatory skin diseases. , 1998, The American journal of pathology.

[145]  E. Corder,et al.  Apolipoprotein E and herpes simplex virus 1 in Alzheimer's disease , 1998, The Lancet.

[146]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[147]  D. Appelt,et al.  Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain , 1998, Medical Microbiology and Immunology.

[148]  R B D'Agostino,et al.  Lifetime risk of dementia and Alzheimer's disease , 1997, Neurology.

[149]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[150]  Konrad Maurer,et al.  Auguste D and Alzheimer's disease , 1997, The Lancet.

[151]  M. Billingsley,et al.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. , 1997, The Biochemical journal.

[152]  J. Kim.  Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil. , 1997, Molecules and cells.

[153]  G. Wilcock,et al.  Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.

[154]  Khadija Iqbal,et al.  Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[155]  P. Lansbury,et al.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.

[156]  B. Ghetti,et al.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[157]  J. Trojanowski,et al.  Neurofibrillary pathology and aluminum in Alzheimer's disease. , 1995, Histology and histopathology.

[158]  David F. Clayton,et al.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.

[159]  B. Chesebro,et al.  A 60-kDa Prion Protein (PrP) with Properties of Both the Normal and Scrapie-associated Forms of PrP (*) , 1995, The Journal of Biological Chemistry.

[160]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[161]  F. Cohen,et al.  Prion protein gene variation among primates. , 1995, Journal of molecular biology.

[162]  H. Mori,et al.  Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid. , 1994, Biochemical and biophysical research communications.

[163]  J. Trojanowski,et al.  Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.

[164]  H. van der Loos,et al.  Further ultrastructural evidence that spirochaetes may play a role in the aetiology of Alzheimer's disease. , 1994, Neuroreport.

[165]  D. Gajdusek,et al.  Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses , 1994, Molecular Neurobiology.

[166]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[167]  Khadija Iqbal,et al.  Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. , 1993, The Journal of biological chemistry.

[168]  J. Miklossy,et al.  Alzheimer's disease—a spirochetosis? , 1993, Neuroreport.

[169]  W. D. Ehmann,et al.  Laser microprobe analysis of brain aluminum in Alzheimer' disease , 1993, Annals of neurology.

[170]  G. Wilcock,et al.  Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type , 1992, The Journal of pathology.

[171]  W. Müller,et al.  Accumulation of transcripts coding for prion protein in human astrocytes during infection with human immunodeficiency virus. , 1992, Biochimica et biophysica acta.

[172]  G. Wilcock,et al.  Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains , 1991, Journal of medical virology.

[173]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[174]  W. Dittrich,et al.  Learning deficiencies in borna disease virus-infected but clinically healthy rats , 1989, Biological Psychiatry.

[175]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[176]  R. Scheller,et al.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[177]  J. Walker,et al.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[178]  D. Bal,et al.  Perspectives on the etiology of Alzheimer's disease. , 1987, JAMA.

[179]  D. McLachlan,et al.  Aluminum and alzheimer's disease , 1986, Neurobiology of Aging.

[180]  S. Prusiner,et al.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene , 1986, Cell.

[181]  S. Mirra,et al.  HTLV-III/LAV infection of the central nervous system in a 57-year-old man with progressive dementia of unknown cause. , 1986, The New England journal of medicine.

[182]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[183]  H. Wiśniewski,et al.  Senile dementia of the Alzheimer type: Possibility of infectious etiology in genetically susceptible individuals , 1984, Acta neurologica Scandinavica. Supplementum.

[184]  E. Renvoize,et al.  Cytomegalovirus infection and Alzheimer's disease. , 1984, Age and Ageing.

[185]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[186]  A. Salazar,et al.  Alzheimer's Disease and Transmissible Virus Dementia (Creutzfeldt‐Jakob Disease) , 1982, Annals of the New York Academy of Sciences.

[187]  C. Masters,et al.  The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. , 1981, Brain : a journal of neurology.

[188]  M. Petrič,et al.  HERPES-SIMPLEX VIRAL GENOME AND SENILE AND PRESENILE DEMENTIAS OF ALZHEIMER AND PICK , 1980, The Lancet.

[189]  Ball Mj.  Features of Creutzfeldt-Jakob Disease in Brains of Patients with Familial Dementia of Alzheimer Type , 1980, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[190]  C Peter N Watson.  Clinical similarity of Alzheimer and Creutzfeldt‐Jakob disease , 1979, Annals of neurology.

[191]  R. Sutton,et al.  DETECTION OF HERPES-SIMPLEX VIRAL GENOME IN BRAIN TISSUE , 1979, The Lancet.

[192]  S. Rajah,et al.  POSSIBLE ASSOCIATION OF ALZHEIMER'S DISEASE WITH HLA-BW15 AND CYTOMEGALOVIRUS INFECTION , 1979, The Lancet.

[193]  J. Austin,et al.  Precautions in familial transmissible dementia: including familial Alzheimer's disease. , 1978, Archives of neurology.

[194]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[195]  G. Ladurner,et al.  IMPROVED LOCALISATION BY SUBTRACTION OF E.M.I. SCANS , 1975, The Lancet.

[196]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[197]  G. Keele.  COOPERATION BETWEEN SOCIAL WORKERS AND GENERAL PRACTITIONERS , 1975, The Lancet.

[198]  E. Lycke,et al.  A Serological Study on Mentally Ill Patients , 1974, British Journal of Psychiatry.

[199]  M. Thouless,et al.  Association between Psychopathic Disorder and Serum Antibody to Herpes Simplex Virus (Type 1) , 1971, British medical journal.

[200]  O. Latham,et al.  ALZHEIMER'S DISEASE COMPLICATED BY A TERMINAL SALMONELLA INFECTION , 1947, Medical Journal of Australia.

[201]  N. Qadi,et al.  Genetic Study of Alzheimer's Disease in Saudi Population. , 2019, Journal of Alzheimer's disease : JAD.

[202]  M. Pohanka.  Oxidative stress in Alzheimer disease as a target for therapy. , 2018, Bratislavske lekarske listy.

[203]  T. Murray,et al.  Connections Between Herpes Simplex Virus Type 1 and Alzheimer's Disease Pathogenesis. , 2016, Current Alzheimer Research.

[204]  F. Mollinedo,et al.  Lipid rafts as major platforms for signaling regulation in cancer. , 2015, Advances in biological regulation.

[205]  Global, regional, and national incidence, prevalence, and YLDs for 301 acute and chronic diseases and injuries for 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015 .

[206]  R. Mayeux,et al.  Review - Part of the Special Issue: Alzheimer's Disease - Amyloid, Tau and Beyond Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers , 2014 .

[207]  W. Deng,et al.  Validating GWAS-Identified Risk Loci for Alzheimer’s Disease in Han Chinese Populations , 2014, Molecular Neurobiology.

[208]  M. J. BALL,et al.  Features of Creutzfeldt-Jakob Disease in Brains of Patients with Familial Dementia of Alzheimer Type , 2014 .

[209]  Sudha Seshadri,et al.  Genetics of Alzheimer's disease. , 2014, Advances in genetics.

[210]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[211]  S. Glantz,et al.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. , 2010, Journal of Alzheimer's disease : JAD.

[212]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[213]  A. Roses.  On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. , 2006, Journal of Alzheimer's disease : JAD.

[214]  T. Südhof,et al.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.

[215]  A. Serretti,et al.  Genes involved in Alzheimer's disease, a survey of possible candidates. , 2005, Journal of Alzheimer's disease : JAD.

[216]  R. Vassar.  BACE1: the beta-secretase enzyme in Alzheimer's disease. , 2004, Journal of molecular neuroscience : MN.

[217]  N. Hooper,et al.  ADAMs family members as amyloid precursor protein alpha-secretases. , 2003, Journal of neuroscience research.

[218]  J. Regula,et al.  Reconstitution of gamma-secretase activity. , 2003, Nature cell biology.

[219]  M. V. van Breemen,et al.  Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. , 2003, Acta neuropathologica.

[220]  S. Lindquist,et al.  Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. , 2003, Science.

[221]  J. Sodroski,et al.  Stimulation of enveloped virus infection by beta-amyloid fibrils. , 2002, The Journal of biological chemistry.

[222]  Y. Kitamura,et al.  NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases. , 2002, Acta neuropathologica.

[223]  K. Arima,et al.  Tubulin seeds alpha-synuclein fibril formation. , 2002, The Journal of biological chemistry.

[224]  L. Thal,et al.  Characterization of the human alpha-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms. , 2001, Journal of Alzheimer's disease : JAD.

[225]  L. Thal,et al.  Characterization of the human α-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms 1 , 2001 .

[226]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[227]  Sheila M. Thomas,et al.  Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.

[228]  F E Cohen,et al.  Prion protein gene variation among primates. , 1997, Journal of molecular biology.

[229]  P. Levallois.  Aluminum and Alzheimer's disease. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[230]  P. Fraser,et al.  Aluminium and the pathogenesis of Alzheimer's disease: a summary of evidence. , 1992, Ciba Foundation symposium.

[231]  Martin N. Rossor,et al.  GENETICS OF ALZHEIMERS-DISEASE , 1990 .

[232]  D. Bal,et al.  Perspectives on the etiology of Alzheimerʼs disease , 1987 .